AngioDynamics ANGO Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| -$8.08M-27.3% | -$6.35M+41.8% | -$10.9M-80.2% | -$6.05M-37.3% | -$4.41M+59.0% | ||
| $5.59M-2.7% | $5.75M-4.5% | $6.02M+3.2% | $5.83M-7.7% | $6.32M-7.9% | ||
| $2.68M-7.2% | $2.89M-35.3% | $4.47M+172% | $1.64M-31.6% | $2.4M-5.1% | ||
| —— | -$48K-200% | -$16K— | —— | -$207K+16.9% | ||
| $38K-87.6% | $307K+1,237% | -$27K+72.2% | -$97K-355% | $38K-2.6% | ||
| $317K+235% | -$235K-318% | $108K-36.1% | $169K+19.0% | $142K+20.3% | ||
| $1.42M-9.6% | $1.57M+1,228% | -$139K+68.9% | -$447K-194% | $474K— | ||
| -$7.06M-315% | $3.28M+1,609% | $192K— | —— | —— | ||
| -$6.01M— | —— | -$10.7M— | —— | -$10.96M— | ||
| $4.08M— | —— | $5.53M+144% | -$12.55M-234% | $9.39M+1,329% | ||
| -$315K-32.4% | -$238K+9.8% | -$264K-85.9% | -$142K-373% | -$30K— | ||
| -$3.11M— | —— | -$15.91M— | —— | -$13.16M— | ||
| $1.02M+141% | $422K-42.3% | $731K-5.9% | $777K-56.8% | $1.8M+126% | ||
| -$1.51M+7.0% | -$1.62M-4.5% | -$1.55M+40.9% | -$2.62M+17.7% | -$3.19M-62.6% | ||
| $0— | $0— | $0— | —— | —— | ||
| $716K— | —— | $234K— | —— | $895K— | ||
| $95K+3.3% | $92K+1.1% | $91K+1.1% | $90K+55.2% | $58K— | ||
| $621K— | —— | $143K+102% | -$5.77M-181% | $7.15M+736% | ||
| $168K— | —— | $191K-73.3% | $715K+659% | -$128K+58.0% | ||
| -$3.83M— | —— | -$17.13M— | —— | -$9.33M-918% | ||
| —— | —— | —— | $46.25K0.0% | $46.25K0.0% | ||
| —— | —— | —— | $200K0.0% | $200K0.0% | ||
| —— | —— | —— | $68K0.0% | $68K0.0% | ||
| $0— | $0— | $0— | —— | $40K-74.4% | ||
| —— | —— | —— | -$247K0.0% | -$247K0.0% | ||
| —— | —— | —— | $0— | $0— | ||
| $38K-87.6% | $307K+1,237% | -$27K— | —— | $38K-2.6% | ||
| $4.08M— | —— | $5.53M+144% | -$12.55M-234% | $9.39M+1,329% | ||
| $72K— | —— | —— | —— | $0— | ||
| $350K-13.6% | $405K-9.0% | $445K— | —— | $503K+0.8% | ||
| —— | —— | —— | $489.5K0.0% | $489.5K0.0% | ||
| -$315K-32.4% | -$238K+9.8% | -$264K-85.9% | -$142K-373% | -$30K— | ||
| $317K+235% | -$235K-318% | $108K-36.1% | $169K+19.0% | $142K+20.3% | ||
| —— | —— | —— | $0— | $0— | ||
| —— | —— | —— | $1.43M0.0% | $1.43M0.0% | ||
| —— | —— | —— | $0— | $0— | ||
| $95K+3.3% | $92K+1.1% | $91K+1.1% | $90K+55.2% | $58K— | ||
| $716K— | —— | $234K— | —— | $895K— | ||
| —— | —— | —— | $233.25K0.0% | $233.25K0.0% | ||
| —— | —— | —— | $46.25K0.0% | $46.25K0.0% | ||
| -$445K-185% | $524K+657% | -$94K-67.9% | -$56K+86.1% | -$404K-191% | ||
| $492K-59.0% | $1.2M+46.2% | $820K— | —— | $1.39M+19.5% | ||
| —— | —— | —— | $0— | $0— | ||
| —— | —— | —— | $1.58M0.0% | $1.58M0.0% | ||
| —— | —— | —— | $200K0.0% | $200K0.0% | ||
| -$4.13M— | —— | -$16.65M— | —— | -$14.96M— | ||
| -$4.13M— | —— | -$16.65M— | —— | -$14.96M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does AngioDynamics generate?
- AngioDynamics (ANGO) generated -$50.4M in operating cash flow over the trailing twelve months.
- What is AngioDynamics's free cash flow?
- After $2.9M of capital expenditures, AngioDynamics's free cash flow was -$55.1M over the trailing twelve months, up 26.8% year over year.
- Where does AngioDynamics's cash flow data come from?
- Every line is extracted from AngioDynamics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
